PL371121A1 - Kompozycja farmaceutyczna zawierająca budesonid jako substancję czynną - Google Patents
Kompozycja farmaceutyczna zawierająca budesonid jako substancję czynnąInfo
- Publication number
- PL371121A1 PL371121A1 PL03371121A PL37112103A PL371121A1 PL 371121 A1 PL371121 A1 PL 371121A1 PL 03371121 A PL03371121 A PL 03371121A PL 37112103 A PL37112103 A PL 37112103A PL 371121 A1 PL371121 A1 PL 371121A1
- Authority
- PL
- Poland
- Prior art keywords
- active ingredient
- pharmaceutical formulation
- layer
- binding agent
- bound
- Prior art date
Links
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title abstract 2
- 229960004436 budesonide Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000011230 binding agent Substances 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 239000008363 phosphate buffer Substances 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10214002A DE10214002A1 (de) | 2002-03-27 | 2002-03-27 | Pharmazeutische Formulierung für den Wirkstoff Budesonid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL371121A1 true PL371121A1 (pl) | 2005-06-13 |
| PL206241B1 PL206241B1 (pl) | 2010-07-30 |
Family
ID=27816040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL371121A PL206241B1 (pl) | 2002-03-27 | 2003-03-06 | Kompozycja farmaceutyczna zawierająca budesonid jako substancję czynną, sposób jej wytwarzania oraz zastosowanie |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20050089571A1 (pl) |
| EP (1) | EP1487421B1 (pl) |
| JP (1) | JP4488171B2 (pl) |
| KR (1) | KR101200286B1 (pl) |
| AT (1) | ATE316784T1 (pl) |
| AU (1) | AU2003212306A1 (pl) |
| BR (1) | BR0308761A (pl) |
| CA (1) | CA2478506C (pl) |
| DE (2) | DE10214002A1 (pl) |
| ES (1) | ES2256722T3 (pl) |
| IL (2) | IL162267A0 (pl) |
| MX (1) | MXPA04009378A (pl) |
| PL (1) | PL206241B1 (pl) |
| WO (1) | WO2003080032A2 (pl) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10220470A1 (de) * | 2002-04-30 | 2003-11-20 | Roehm Gmbh | ph-sensitives Polymer |
| US8895064B2 (en) | 1999-06-14 | 2014-11-25 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
| EP1183014B1 (en) | 1999-06-14 | 2003-10-08 | Cosmo S.p.A. | Controlled release and taste masking oral pharmaceutical compositions |
| DE10011447A1 (de) * | 2000-03-10 | 2001-09-20 | Roehm Gmbh | Dispersion mit nichtionischem Emulgator |
| US7616996B2 (en) * | 2005-09-01 | 2009-11-10 | Intrapace, Inc. | Randomized stimulation of a gastrointestinal organ |
| US6535764B2 (en) * | 2001-05-01 | 2003-03-18 | Intrapace, Inc. | Gastric treatment and diagnosis device and method |
| US7979127B2 (en) * | 2001-05-01 | 2011-07-12 | Intrapace, Inc. | Digestive organ retention device |
| DE10208335A1 (de) * | 2002-02-27 | 2003-09-04 | Roehm Gmbh | Arzneiform und Verfahren zu ihrer Herstellung |
| MXPA04010956A (es) * | 2003-01-30 | 2005-01-25 | Roehm Gmbh | Forma de dosis farmaceutica y metodo para la produccion de la misma. |
| DE602004028497D1 (de) * | 2003-09-15 | 2010-09-16 | Nycomed Gmbh | Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen |
| GB0403247D0 (en) * | 2004-02-13 | 2004-03-17 | Tillotts Pharma Ag | A pharmaceutical composition |
| DE102004035936A1 (de) * | 2004-07-23 | 2006-03-16 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform |
| AU2006249100B2 (en) | 2005-05-18 | 2012-01-19 | Assistance Publique - Hospitaux De Paris | Colonic delivery of adsorbents |
| US7509175B2 (en) | 2006-08-03 | 2009-03-24 | Intrapace, Inc. | Method and devices for stimulation of an organ with the use of a transectionally placed guide wire |
| US8048413B2 (en) | 2006-05-17 | 2011-11-01 | Helene Huguet | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
| WO2007145191A1 (ja) | 2006-06-13 | 2007-12-21 | Nippon Shinyaku Co., Ltd. | 被覆錠剤 |
| ES2311373B1 (es) * | 2006-09-27 | 2009-12-21 | Dmc Research Center, S.L. | "utilizacion de un compuesto antibacteriano derivado de alliaceas, como aditivos en alimentacion animal". |
| US20100209520A1 (en) * | 2007-03-26 | 2010-08-19 | Hiroyuki Kubo | Oral pharmaceutical preparation for colon-specific delivery |
| WO2009079566A2 (en) | 2007-12-18 | 2009-06-25 | Acumen Pharmaceuticals, Inc. | Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production |
| JP4864024B2 (ja) * | 2008-02-15 | 2012-01-25 | エスエス製薬株式会社 | 時限放出製剤 |
| GB0808537D0 (en) | 2008-05-12 | 2008-06-18 | Archimedes Dev Ltd | Compositions |
| DE102008048729A1 (de) * | 2008-09-24 | 2010-03-25 | Add Technologies Ltd Advanced Drug Delivery | Multipartikuläre Tabletten und Verfahren zur deren Herstellung |
| US8945616B2 (en) | 2009-02-17 | 2015-02-03 | Mylan Pharmaceuticals Inc. | Controlled release budesonide minitablets |
| US8945615B2 (en) * | 2009-02-17 | 2015-02-03 | Mylan Pharmaceuticals Inc. | Controlled release budesonide minitablets |
| US10154964B2 (en) | 2011-09-07 | 2018-12-18 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
| IN2014CH01890A (pl) * | 2014-04-10 | 2015-10-16 | Aurobindo Pharma Ltd | |
| CA2902911C (en) | 2014-10-31 | 2017-06-27 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
| JP6824197B2 (ja) | 2015-06-05 | 2021-02-03 | エボニック オペレーションズ ゲーエムベーハー | エタノールの影響に対する耐性を有する医薬品組成物または栄養機能食品組成物 |
| EP3346996A4 (en) | 2015-09-11 | 2019-04-17 | Sun Pharmaceutical Industries Limited | ORAL PHARMACEUTICAL PHARMACEUTICAL FORM OF BUDESONID |
| EP3613414A1 (de) * | 2018-08-24 | 2020-02-26 | Dr. Falk Pharma Gmbh | Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon |
| US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| CA3216303A1 (en) * | 2021-04-20 | 2022-10-27 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Capsule for specific drug delivery and preparation method therefor |
| US11896719B2 (en) | 2022-01-24 | 2024-02-13 | Calliditas Therapeutics Ab | Pharmaceutical compositions |
| US12303604B1 (en) | 2024-10-16 | 2025-05-20 | Currax Pharmaceuticals Llc | Pharmaceutical formulations comprising naltrexone and/or bupropion |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5643602A (en) * | 1989-11-22 | 1997-07-01 | Astra Aktiebolag | Oral composition for the treatment of inflammatory bowel disease |
| US5260068A (en) * | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
| DE4332394A1 (de) * | 1993-09-23 | 1995-03-30 | Falk Pharma Gmbh | Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung |
| DE4402666A1 (de) * | 1994-01-29 | 1995-08-03 | Roehm Gmbh | Verfahren zum kurzzeitigen Behandeln einer Kunststoffschmelze mit einem flüssigen Behandlungsmittel und dabei hergestellter thermoplastischer Kunststoff |
| DE9414066U1 (de) * | 1994-08-31 | 1994-11-03 | Röhm GmbH & Co. KG, 64293 Darmstadt | Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform |
| DE9414065U1 (de) * | 1994-08-31 | 1994-11-03 | Röhm GmbH & Co. KG, 64293 Darmstadt | Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen |
| DE19544562B4 (de) * | 1995-11-30 | 2004-05-27 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von Poly(meth)acrylimiden mit bei thermischer Belastung verbesserter Farbstabilität und daraus erhältliche Formkörper |
| DE19718597C1 (de) * | 1997-05-02 | 1999-01-07 | Roehm Gmbh | Zweistufiges Verfahren zur Entwässerung von Kunststoffdispersionen |
| TR200100777T2 (tr) * | 1998-09-18 | 2001-12-21 | Rohm Gmbh & Co. Kg | Bilgi taşıyıcı ham disketler için şekillendirme aleti. |
| DE10220470A1 (de) * | 2002-04-30 | 2003-11-20 | Roehm Gmbh | ph-sensitives Polymer |
| DE10011447A1 (de) * | 2000-03-10 | 2001-09-20 | Roehm Gmbh | Dispersion mit nichtionischem Emulgator |
| DE10013029A1 (de) * | 2000-03-17 | 2001-09-20 | Roehm Gmbh | Mehrschichtige Arzneiform für die Colonfreigabe |
| DE10065492A1 (de) * | 2000-12-28 | 2003-06-26 | Roehm Gmbh | Diffus ausgestattete Formmassen und hieraus erhältliche Formkörper |
| SK287902B6 (sk) * | 2001-01-31 | 2012-03-02 | Evonik Rohm Gmbh | Multiparticulate drug form and method for the preparation thereof |
| DE10208335A1 (de) * | 2002-02-27 | 2003-09-04 | Roehm Gmbh | Arzneiform und Verfahren zu ihrer Herstellung |
-
2002
- 2002-03-27 DE DE10214002A patent/DE10214002A1/de not_active Withdrawn
-
2003
- 2003-03-06 KR KR1020047015369A patent/KR101200286B1/ko not_active Expired - Fee Related
- 2003-03-06 AU AU2003212306A patent/AU2003212306A1/en not_active Abandoned
- 2003-03-06 WO PCT/EP2003/002269 patent/WO2003080032A2/de not_active Ceased
- 2003-03-06 MX MXPA04009378A patent/MXPA04009378A/es active IP Right Grant
- 2003-03-06 DE DE50302336T patent/DE50302336D1/de not_active Expired - Lifetime
- 2003-03-06 AT AT03708180T patent/ATE316784T1/de active
- 2003-03-06 IL IL16226703A patent/IL162267A0/xx unknown
- 2003-03-06 BR BR0308761-1A patent/BR0308761A/pt not_active IP Right Cessation
- 2003-03-06 ES ES03708180T patent/ES2256722T3/es not_active Expired - Lifetime
- 2003-03-06 US US10/501,236 patent/US20050089571A1/en not_active Abandoned
- 2003-03-06 CA CA002478506A patent/CA2478506C/en not_active Expired - Fee Related
- 2003-03-06 PL PL371121A patent/PL206241B1/pl not_active IP Right Cessation
- 2003-03-06 JP JP2003577862A patent/JP4488171B2/ja not_active Expired - Fee Related
- 2003-03-06 EP EP03708180A patent/EP1487421B1/de not_active Expired - Lifetime
-
2004
- 2004-06-01 IL IL162267A patent/IL162267A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL206241B1 (pl) | 2010-07-30 |
| JP4488171B2 (ja) | 2010-06-23 |
| JP2005521696A (ja) | 2005-07-21 |
| KR20040102060A (ko) | 2004-12-03 |
| MXPA04009378A (es) | 2005-01-25 |
| EP1487421A2 (de) | 2004-12-22 |
| AU2003212306A1 (en) | 2003-10-08 |
| WO2003080032A3 (de) | 2004-01-08 |
| ATE316784T1 (de) | 2006-02-15 |
| CA2478506C (en) | 2009-09-08 |
| WO2003080032A2 (de) | 2003-10-02 |
| KR101200286B1 (ko) | 2012-11-13 |
| IL162267A0 (en) | 2005-11-20 |
| DE50302336D1 (de) | 2006-04-13 |
| US20050089571A1 (en) | 2005-04-28 |
| CA2478506A1 (en) | 2003-10-02 |
| EP1487421B1 (de) | 2006-02-01 |
| ES2256722T3 (es) | 2006-07-16 |
| IL162267A (en) | 2010-02-17 |
| BR0308761A (pt) | 2005-01-11 |
| DE10214002A1 (de) | 2003-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL162267A0 (en) | Pharmaceutical formulation for the active ingredient budesonide | |
| AU2001255509B2 (en) | Taste masking coating composition | |
| JP4979180B2 (ja) | 薬学的に活性な薬剤の浸透送達のためのシステム | |
| US11324721B2 (en) | Secnidazole for use in the treatment of trichomoniasis | |
| MX9500885A (es) | Preparacion farmaceutica para administracion oral. | |
| WO2006044202A3 (en) | Enteric coated compositions that release active ingredient(s) in gastric fluid and intestinal fluid | |
| CA2400567A1 (en) | Tamper-resistant oral opioid agonist formulations | |
| AU3345197A (en) | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof | |
| CN105163743A (zh) | 用于治疗幽门螺杆菌的药物组合物 | |
| US20070099843A1 (en) | Nutritional supplement for the enhancement of the health of the liver | |
| Nagaveni et al. | A Complete Review on Mucoadhesive Buccal Tablets | |
| AU2014239683B2 (en) | Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability | |
| US5549911A (en) | Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract | |
| AU705570B2 (en) | Microgranules of 5-nitro imidazole derivatives | |
| RU96117257A (ru) | Галеновая форма производных 5-нитроимидазола | |
| JPS6115829A (ja) | 口腔粘膜適用徐放性ニフエジピン製剤 | |
| WO2022115481A1 (en) | Methods and compositions for treating post-acute infection gastrointestinal disorders | |
| JP2014189547A (ja) | 嚥下物被覆体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Decisions on the lapse of the protection rights |
Effective date: 20130306 |